Wilson Sonsini Goodrich & Rosati represented Lyft in the offering, and Goodwin Procter represented the initial purchasers. Lyft, Inc. (“Lyft”) (NASDAQ: LYFT) closed its offering of 0.625%...
You must be a Standard 1 Year member to access this content.
Goodwin advised Rocket Lab USA, Inc. on the offering. Rocket Lab USA, Inc. (Nasdaq: RKLB), a global leader in launch services and space systems, announced the...
You must be a Standard 1 Year member to access this content.
Goodwin advised the initial purchasers on Amphastar Pharmaceuticals, Inc.’s offering. Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced the Rule 144A offering of 2.00% Convertible Senior Notes due...
You must be a Standard 1 Year member to access this content.
Goodwin advised Arrowroot Acquisition Corp. on the deal. Arrowroot Acquisition Corp. (NASDAQ:ARRW) announced its merger agreement with iLearningEngines. Upon closing of the transaction, the combined company will...
You must be a Standard 1 Year member to access this content.
Goodwin advised Avadel on the deal. Avadel extended the maturity of $96.2 million of its convertible notes to 2027. Under the terms of the convertible note exchange...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised TPI Composites, Inc. on the deal. Davis Polk advised the representative of the initial purchasers and the counterparties to the capped call transactions...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the initial purchasers on the deal. Sarepta Therapeutics, Inc. announced its Rule 144A offering of 1.25% Convertible Senior Notes due 2027. The $1.15 billion...
You must be a Standard 1 Year member to access this content.
Goodwin Procter represented Wayfair, while Davis Polk advised the representatives of the initial purchasers in the offering. Wayfair Inc. completed its offering of $690 million aggregate principal...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Alnylam Pharmaceuticals, Inc. on the deal, while Davis Polk advised the representative of the initial purchasers. Alnylam Pharmaceuticals, Inc. announced its inaugural offering...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Thoma Bravo, while Goodwin Procter advised SailPoint Technologies Holdings, Inc. on the deal. Latham & Watkins represented the direct lenders in the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented OpenSea, while Goodwin represented Dharma Labs in the transaction. OpenSea, an nonfungible token (NFT) marketplace, has announced that it is acquiring Dharma Labs....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Global Blood Therapeutics on the deal. Global Blood Therapeutics, Inc. (Nasdaq: GBT) announced its offering of 1.875% Convertible Senior Notes due 2028. The...
You must be a Standard 1 Year member to access this content.
